NCT01728259 2023-05-09First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDBarbara Ann Karmanos Cancer InstitutePhase 1 Terminated18 enrolled
NCT03000660 2020-08-21Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL AmyloidosisTufts Medical CenterPhase 1 Terminated3 enrolled